Grand Decade and existing investor Boehringer Ingelheim Venture Fund helped supply $38.2m for the mRNA immunotherapy developer and Vrije Universiteit Brussel spinout.

Grand Decade and existing investor Boehringer Ingelheim Venture Fund helped supply $38.2m for the mRNA immunotherapy developer and Vrije Universiteit Brussel spinout.

The gig worker support service secured $15m in a round led by Recruit Strategic Partners that also featured CMFG Ventures and existing investor Propel Venture Partners.

Toyota AI Ventures, Micron Ventures, Hella Ventures and Presidio Ventures have all invested in the video analytics system developer.

Slack-backed smart calendar developer Clockwise has now raised $31m altogether, Bain Capital Ventures having led its series B round.

The Roche, Novartis and Kraft Group-backed, protein degradation-focused drug developer received $150m in series B funding and $20m in venture debt.

Next47 and M12 took part in Wandelbots' latest round, which came as it publicly launched its robotics training software tool.

Based on research from academic schools including Princeton, Chicago and Alabama at Birmingham, the oncolytic viral therapy developer has now received more than $80m to date.

Remote care platform developer Conversa increased its total funding to more than $26m in a round co-led by Northwell Ventures and backed by UH Ventures.

Dell Technologies Capital and Wipro Ventures contributed to a round that advanced the total raised by the open source database software provider to $55m.